| Trade date | Director | Volume / Price | Trade value | Trade type |
|---|---|---|---|---|
| No director deals found. | ||||
| Name | Holding | Percent |
|---|---|---|
| Carolyn Cross | 155,864,029 | 38.00% |
| Nicolas Loebel | 3,513,991 | 0.00% |
| Junaid Bajwa | 1,193,697 | 0.00% |
| Jean Duvall | 1,163,529 | 0.00% |
| Michael Farrar | 484,806 | 0.00% |
| Jean Charest | 353,356 | 0.00% |
| Simon Sinclair | 256,327 | 0.00% |
| Institution name | Holding | Percent |
|---|---|---|
| Robert Cross | 25,858,400 | 13.30% |
| Albemarle Life Sciences Fund | 15,105,882 | 3.83% |
| CRUX Asset Management | 9,298,090 | 4.78% |
| Chelverton Asset Management | 7,957,311 | 4.09% |